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places there is confusion as to which of the
two is ineant. Whilst there is no full agreement
on the exact form of nomenclature, it is
clear that the use of block capitals as used
earlier in this reviewN, (a recent workshop
publication (Blood Cells (1979) 5, 447) on
nomenclature specifically recommends at
least that much) easily removes this source of
confusion and/or error.
The discussion sections (often the most
informative part of such a work) suffer from
the fact that they are presented as a con-
tinuum at the end of each section. It is
frequently difficult to determine to whom a
question is addressed and to what specific
point it refers. A collective discussion can
work well at a conference but requires very
careful editing when presented in a subse-
quent printed version. The English is con-
sistently infuriating and apart from badly con-
structed sentences there are many examples
of old chestnuts. For example, "a number"
is a singular noun, and used as the subject of
a sentence requires the singular form of the
verb. There are several "single media" plus
a survival optima" and, of course, split
infinitives abound.
The specialist (and in particular the con-
ference participants) will find the book
valuable. I, in spite of its shortcomings, am
happy to have a copy on my bookshelf.
B. I. LORD
Treatment of Radioresistant Cancers.
(Eds) M. ABE, K. SAKAMOTO & T. L.
PHILIPS (1979). New York: Elsevier. 230pp.
This volume is the proceedings in camera-
ready form of an International Symposium
on the prospects for treatment of radio-
resistant cancers, held in Kyoto in May 1979.
The title will appeal instantly to optimistic
and forward-looking radiotherapists, but
they will be disappointed, as the subject of
the title is discussed diirectly only in 2
chapters in the last section, in which there is
a short review of soft-tissue sarcoma (Suit)
including some new data, with the opinion
that these tumours should not now be
considered particularly radioresistant, and a
trial of uneven fractionation r-eported for
bronchogenic carcinoma (Takahashi) using
600 rad plus 4 subsequent fractions of 120
irad each week for 5 weeks. However, the
results, slightly better than for historical
conventional treatments, are no better than
others have claimed for conventional sched-
ules. The use of bleomycin and radiotherapy
for oral carcinoma is described (Shigematsu),
but the true benefit from BLM cannot be
elucidated from the series presented. The
section concludes with a study on the vas-
culature of mouse tumours using resin casts
(Egawa)-technically very satisfying, buit
difficult to quantitate and interpret.
There are 2 sections on methods to over-
come the resistance of most tumours, if this
is caused by hypoxic tumour cells, as is
generally believed. Radiosensitizer scientists
are well represented by Adams (problems and
prospects) Arcangeli (clinical treatnients)
and Phillips (studies in USA). These papers
are right up to date, and usefully concise.
The clinical studies are clearly work-in-
progress, and as yet inconclusive about real
benefit.
High-LET radiation receives good atten-
tion, with neutrons, pions, and heavy ions
being discussed. New biological measurements
with 6 MeV neutrons and pions (Sakamoto)
is followed by the use of 252Cf in a series of
60 patients. This series is well presented, but
is non-randomized and difficult to assess in
relation to conventional treatments. There
is a good trial of fast neutrons (30 MeV d on
Be) using 400 patients (Tsumemoto). The
largest group (cervix-III-B) shows equivalent
local control (neutron/photon) with slightly
more complications after neutrons. Pions
are described at Vancouver (Skarsgard) and
Los Alamos (Kligerman)-the latest inform-
ation, and concisely written. This section
concludes with heavy-ion studies at Berkeley
(Tobias).
The fourth section is on hyperthermia,
containing a good review (Johnson) to join
several others now available. Data are pre-
sented for mouse tumours and foot skin
reactions (Urano) and for a human mel-
anoma cell line (Streffer) showing nuclear
damage after heat.
In general, this is a very mixed collection
ofpapers, with some very good short reviews,
some varying clinical studies, and some
experimental work which should probably
go first into the open literature. The book
does not really deserve its title, although if
retitled 'The current status of new treatments
in radiotherapy' this volume would be a
reasonable attempt.
J. H. HENDRY